A Russia native has brought her education back to her hometown to help people of all ages with physical therapy and wellness.

Eleven-year-old Hayden Thomas enjoys playing tennis with his sister Madilynn. He can even serve the ball, thanks in part to a ...

In 2023, nearly 1 in 4 US adults were living with chronic pain, and 8.5% experienced pain severe enough to limit daily life ...

Vertex Pharmaceuticals' (NASDAQ: VRTX) remarkable momentum came to a screeching halt this week. The big biotech stock had ...

EPS and sales below estimates but raised its 2025 revenue outlook, driven by CF drug demand and new product launches in the U ...

A physical therapist who worked in County had his license to practice suspended by the state after investigations revealed he inappropriately interacted with two patients, and had one perform a sexual ...

A new treatment is available at WVU Medicine Princeton Community Hospital for people dealing with arthritis pain. According ...

PSP said in a Facebook post on Wednesday evening that this would be the party's "first ever" physical rally. In addition to residents of Marymount SMC, PSP also invited those from Kebun Baru SMC ...

With a market cap of $122.6 billion, Vertex Pharmaceuticals Incorporated (VRTX) operates as a global biotechnology company that develops and commercializes therapies for treating cystic fibrosis (CF).

Regulatory submissions are expected in 2026, and if approved, would be the second cell therapy for type 1 diabetes. Vertex Pharmaceuticals is conducting the pivotal phase 3 portion of a phase 1/2/3 ...

ToolGen's CEO Jong Sang Ryu commented, "Vertex's CASGEVY was born from ToolGen's proprietary CRISPR RNP technology. As the company behind the world's first CRISPR Cas9-based gene therapy, we believe ...